175 related articles for article (PubMed ID: 28470853)
1. Role of red blood cells in the anemia-associated bleeding under high shear conditions.
Yaoi H; Shida Y; Ogiwara K; Hosokawa K; Shima M; Nogami K
Haemophilia; 2017 Sep; 23(5):750-758. PubMed ID: 28470853
[TBL] [Abstract][Full Text] [Related]
2. Assessing the clinical severity of type 1 von Willebrand disease patients with a microchip flow-chamber system.
Nogami K; Ogiwara K; Yada K; Shida Y; Takeyama M; Yaoi H; Minami H; Furukawa S; Hosokawa K; Shima M
J Thromb Haemost; 2016 Apr; 14(4):667-74. PubMed ID: 27061057
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of coagulation factor therapy in patients with von Willebrand disease type 3 using a microchip flow chamber system.
Ågren A; Holmström M; Schmidt DE; Hosokawa K; Blombäck M; Hjemdahl P
Thromb Haemost; 2017 Jan; 117(1):75-85. PubMed ID: 27761577
[TBL] [Abstract][Full Text] [Related]
4. Nonsurgical bleeding diathesis in anemic thrombocytopenic patients: role of temperature, red blood cells, platelets, and plasma-clotting proteins.
Valeri CR; Khuri S; Ragno G
Transfusion; 2007 Oct; 47(4 Suppl):206S-248S. PubMed ID: 17888061
[TBL] [Abstract][Full Text] [Related]
5. A Novel Microchip Flow Chamber (Total Thrombus Analysis System) to Assess Canine Hemostasis.
Iwanaga T; Miura N; Brainard BM; Brooks MB; Goggs R
Front Vet Sci; 2020; 7():307. PubMed ID: 32582782
[TBL] [Abstract][Full Text] [Related]
6. A microchip flow-chamber assay screens congenital primary hemostasis disorders.
Nakajima Y; Yada K; Ogiwara K; Furukawa S; Shimonishi N; Shima M; Nogami K
Pediatr Int; 2021 Feb; 63(2):160-167. PubMed ID: 32640065
[TBL] [Abstract][Full Text] [Related]
7. Role of red blood cells in clinically relevant bleeding tendencies and complications.
Lassila R; Weisel JW
J Thromb Haemost; 2023 Nov; 21(11):3024-3032. PubMed ID: 37210074
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of the Total Thrombus-Formation Analysis System (T-TAS) in the diagnosis and characterization of von Willebrand disease.
Daidone V; Barbon G; Cattini MG; Pontara E; Romualdi C; Di Pasquale I; Hosokawa K; Casonato A
Haemophilia; 2016 Nov; 22(6):949-956. PubMed ID: 27293213
[TBL] [Abstract][Full Text] [Related]
9. Studies of a microchip flow-chamber system to characterize whole blood thrombogenicity in healthy individuals.
Yamaguchi Y; Moriki T; Igari A; Matsubara Y; Ohnishi T; Hosokawa K; Murata M
Thromb Res; 2013 Aug; 132(2):263-70. PubMed ID: 23777751
[TBL] [Abstract][Full Text] [Related]
10. Effects of red blood cell concentration on hemostasis and thrombus formation in a primate model.
Cadroy Y; Hanson SR
Blood; 1990 Jun; 75(11):2185-93. PubMed ID: 2346782
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive evaluation of haemostatic function in von Willebrand disease patients using a microchip-based flow chamber system.
Ogiwara K; Nogami K; Hosokawa K; Ohnishi T; Matsumoto T; Shima M
Haemophilia; 2015 Jan; 21(1):71-80. PubMed ID: 25545301
[TBL] [Abstract][Full Text] [Related]
12. Effects of red blood cells on hemostasis.
Roeloffzen WW; Kluin-Nelemans HC; Bosman L; de Wolf JT
Transfusion; 2010 Jul; 50(7):1536-44. PubMed ID: 20158685
[TBL] [Abstract][Full Text] [Related]
13. Red blood cells: the forgotten player in hemostasis and thrombosis.
Weisel JW; Litvinov RI
J Thromb Haemost; 2019 Feb; 17(2):271-282. PubMed ID: 30618125
[TBL] [Abstract][Full Text] [Related]
14. Anemia-Induced Bleeding in Patients with Platelet Disorders.
Thakar S; Gabarin N; Gupta A; Radford M; Warkentin TE; Arnold DM
Transfus Med Rev; 2021 Jul; 35(3):22-28. PubMed ID: 34332828
[TBL] [Abstract][Full Text] [Related]
15. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
[TBL] [Abstract][Full Text] [Related]
16. A novel quantitative method to evaluate the contribution of platelet products to white thrombus formation in reconstituted blood under flow conditions.
Fuchizaki A; Yasui K; Hayashi T; Tanaka M; Nagasato T; Ohnishi-Wada T; Hosokawa K; Fujimura Y; Shimogaki K; Hirayama F; Takihara Y; Kimura T
Vox Sang; 2023 May; 118(5):367-375. PubMed ID: 36862116
[TBL] [Abstract][Full Text] [Related]
17. Stored erythrocytes have less capacity than normal erythrocytes to support primary haemostasis.
Reinhart WH; Zehnder L; Schulzki T
Thromb Haemost; 2009 Apr; 101(4):720-3. PubMed ID: 19350117
[TBL] [Abstract][Full Text] [Related]
18. [Von Willebrand disease: a common and unrecognized bleeding disorder].
Boehlen F; Robert-Ebadi H; de Moerloose P
Rev Med Suisse; 2007 Feb; 3(97):346-50. PubMed ID: 17370733
[TBL] [Abstract][Full Text] [Related]
19. An approach to outreach patients with von Willebrand disease in Egypt by targeting women with heavy menstrual bleeding and/or bleeding symptoms.
Sherif N; Goubran H; Hassan A; Burnouf T; El-Ekiaby M
Haemophilia; 2014 Mar; 20(2):238-43. PubMed ID: 24251732
[TBL] [Abstract][Full Text] [Related]
20. Review article: unexpected bleeding in the operating room: the role of acquired von Willebrand disease.
Lison S; Dietrich W; Spannagl M
Anesth Analg; 2012 Jan; 114(1):73-81. PubMed ID: 22025497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
